Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene.
Most papers first2,281 to 2,300 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| TYRO3 TYRO3 protein tyrosine kinase | 7301 HGNC:12446 | 1 | 73 | 0 | 0 | 1,792 | 2,825 |
| ALDOA aldolase, fructose-bisphosphate A | 226 HGNC:414 | 1 | 217 | 0 | 0 | 1,951 | 2,824 |
| CXADR CXADR cell adhesion molecule | 1525 HGNC:2559 | 1 | 69 | 0 | 0 | 1,756 | 2,820 |
| PEBP1 phosphatidylethanolamine binding protein 1 | 5037 HGNC:8630 | 1 | 94 | 0 | 0 | 1,332 | 2,820 |
| LRPAP1 LDL receptor related protein associated protein 1 | 4043 HGNC:6701 | 1 | 115 | 0 | 0 | 2,113 | 2,811 |
| GP2 glycoprotein 2 | 2813 HGNC:4441 | 1 | 55 | 0 | 0 | 1,628 | 2,809 |
| SORT1 sortilin 1 | 6272 HGNC:11186 | 1 | 118 | 0 | 0 | 2,739 | 2,809 |
| CCL1 C-C motif chemokine ligand 1 | 6346 HGNC:10609 | 1 | 125 | 0 | 0 | 1,749 | 2,807 |
| PRKAR1A protein kinase cAMP-dependent type I regulatory subunit alpha | 5573 HGNC:9388 | 1 | 73 | 0 | 0 | 1,475 | 2,806 |
| KMT2B lysine methyltransferase 2B | 9757 HGNC:15840 | 1 | 38 | 0 | 0 | 2,082 | 2,805 |
| P2RY1 purinergic receptor P2Y1 | 5028 HGNC:8539 | 1 | 40 | 2 | 23 | 1,328 | 2,801 |
| CAMKK2 calcium/calmodulin dependent protein kinase kinase 2 | 10645 HGNC:1470 | 1 | 48 | 0 | 0 | 1,686 | 2,799 |
| RAD52 RAD52 DNA repair protein | 5893 HGNC:9824 | 1 | 51 | 0 | 0 | 1,882 | 2,797 |
| SDCBP syndecan binding protein | 6386 HGNC:10662 | 1 | 32 | 0 | 0 | 1,458 | 2,794 |
| CCNE2 cyclin E2 | 9134 HGNC:1590 | 1 | 68 | 0 | 0 | 1,511 | 2,792 |
| MSX2 msh homeobox 2 | 4488 HGNC:7392 | 1 | 39 | 0 | 0 | 1,792 | 2,792 |
| FFAR2 free fatty acid receptor 2 | 2867 HGNC:4501 | 1 | 60 | 1 | 1 | 976 | 2,791 |
| CAV3 caveolin 3 | 859 HGNC:1529 | 1 | 45 | 0 | 0 | 1,674 | 2,790 |
| ITK IL2 inducible T cell kinase | 3702 HGNC:6171 | 1 | 88 | 4 | 235 | 1,876 | 2,789 |
| SLC9A3 solute carrier family 9 member A3 | 6550 HGNC:11073 | 1 | 21 | 4 | 29 | 1,442 | 2,789 |
Code
curl "https://conductscience.org/api/genes/v1?page=115"
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=115
{
"data": {
"total": 193990,
"results": [
{
"id": "7301",
"title": "TYRO3: TYRO3 protein tyrosine kinase",
"summary": "NCBI Gene 7301. 1 protein, 73 patents, 0 drugs, 0 trials, 1,792 NIH grants and 2,825 papers.",
"record": "/library/genes/7301",
"gene_id": 7301,
"symbol": "TYRO3",
"name": "TYRO3 protein tyrosine kinase",
"hgnc_id": "HGNC:12446",
"counts": {
"proteins": 1,
"patents": 73,
"drugs": 0,
"trials": 0,
"grants": 1792,
"papers": 2825
}
},
{
"id": "226",
"title": "ALDOA: aldolase, fructose-bisphosphate A",
"summary": "NCBI Gene 226. 1 protein, 217 patents, 0 drugs, 0 trials, 1,951 NIH grants and 2,824 papers.",
"record": "/library/genes/226",
"gene_id": 226,
"symbol": "ALDOA",
"name": "aldolase, fructose-bisphosphate A",
"hgnc_id": "HGNC:414",
"counts": {
"proteins": 1,
"patents": 217,
"drugs": 0,
"trials": 0,
"grants": 1951,
"papers": 2824
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.2.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "No license stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "Public domain (US government)"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubMed",
"license": "NLM's terms",
"notice": null,
"short": "NLM's terms"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=116",
"request_id": "wWoIof4a0pS7Sfla"
}Ask about these results. The first 10 go in the prompt.
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant